The Food and Drug Administration (FDA) carried out an inspection at Blood Assurance, Inc. in Clarksville on April 9, focusing on blood and blood products, according to data posted on the FDA’s website.
The final report determined no corrective action was necessary with respect to the organization’s management operations.
Routine inspections nationwide by the FDA ensure that workplaces and their products comply with regulations designed to enhance public health. The outcomes of these inspections are made available to the public.
As stated on its official website, the FDA serves as a government agency responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
This article includes information from the U.S. Food and Drug Administration. The original source data is available here.
